-The Indian Express Government’s actions on the commodity reveals it is ignorant of how a market economy is run With each passing day this year, agriculture seems to be sagging and so is the Indian farmer. Deficit monsoon rains appear to be the trigger. Although rains offered some respite to Marathwada, the situation in India’s largest agri-state, Uttar Pradesh, has gone from bad to worse. Last year’s drought, with monsoon rains falling...

-Business Standard Cabinet note soon on Rs 1,800-cr investment over 5 years to boost sector, skills To push fish production, the Centre is formulating a programme to tap water reservoirs and neglected water bodies such as wetlands for breeding through modern technologies. The programme, part of Prime Minister Narendra Modi’s vision of a Blue Revolution, entails Rs 1,800 crore over the next five years, much lower than what was envisaged by a working...

-The Hindu Business Line New Delhi: The prices of pulses can shoot up by 10-15 per cent in the run up to the festival season, according to an Associated Chambers of Commerce of India (Assocham) study released here on Friday. The trade body estimates that India will import over 10 million tonnes (mt) of pulses since domestic production is likely to be limited to around 17 mt on the back of a...

-Business Standard Uttar Pradesh's two main crops, wheat and sugarcane, have been facing a variety of problems in recent months Crop recasting, effective income security and a refocusing of the subsidy pattern to target small and marginal farmers are needed, went a presentation by the Uttar Pradesh agriculture department at the two-day national conference on rabi crops. The presentation was the basis of a discussion on the agrarian problem facing the country. Uttar Pradesh's...

-The Times of India WASHINGTON: India has agreed to supply to the United States generic cancer drugs at a time there is outrage in America about the predatory practices by the US pharma industry, one of whose leaders is getting hammered for increasing the price of life-saving drugs by as much as 5000 per cent overnight. Martin Shkreli, CEO of Turing Pharmaceuticals, is being dubbed the ''poster child for price gouging in...